Quality Investor

Elanco Animal Health Incorporated

Rank #366Startup

ELAN · NYSE · Healthcare

Elanco Animal Health Incorporated (ELAN) — Rank #366 by gross profitability (GP/assets 0.19) · ROE -3.5% · Piotroski F-Score 6 / 9.

As-of 2026-09-15 · CIK 0001739104 · all metrics point-in-time as of the filing date.

About

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide.

Show more

The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians.

Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Filer Category
Large accelerated filer
Fiscal Year End
December 31
Website
elanco.com

Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.

USD in millions, except per-share (EPS) and percentage rows. Values are as originally filed; em-dash = not tagged in that year's filing.
Fiscal year end2025-12-31filed 2026-02-242024-12-31filed 2025-02-252023-12-31filed 2024-02-262022-12-31filed 2023-03-01
Assets
Liabilities
Equity

Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?